ClinicalThought

Share

Program Content

Activities

  • IL-13 Inhibitors for AD CT
    Expert Commentary on the Use of IL-13 Inhibition in Treating Moderate to Severe Atopic Dermatitis
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 19, 2023

Faculty

cover img faculity

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly